CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

The Next-Generation Sequencing Revolution Revitalizes Clinical Metagenomics

The Next-Generation Sequencing...

Element Biosciences Strikes Multiple Partnerships to Integrate Sequencer With Existing NGS Products

Element Biosciences Strikes Multiple...

Technologies that will revolutionize cancer care

Technologies that will revolutionize...

A rise in DNA Sequencing Market is expected in coming years

A rise in DNA Sequencing Market is...

Technologies to have an impact on science this year.

Technologies to have an impact on...

Data Science In R&D: It Is About Culture

Data Science In R&D: It Is About Culture

Three Steps To Succeed With Digital Transformation In Pharma?

Three Steps To Succeed With Digital...

Partnering With A Cdmo For Successful Late Phase Biologic Drug Product Development And Launch

Partnering With A Cdmo For Successful...

The Next-Generation Sequencing Revolution Revitalizes Clinical Metagenomics

The Next-Generation Sequencing...

Element Biosciences Strikes Multiple Partnerships to Integrate Sequencer With Existing NGS Products

Element Biosciences Strikes Multiple...

Technologies that will revolutionize cancer care

Technologies that will revolutionize...

A rise in DNA Sequencing Market is expected in coming years

A rise in DNA Sequencing Market is...

Technologies to have an impact on science this year.

Technologies to have an impact on...

Data Science In R&D: It Is About Culture

Data Science In R&D: It Is About Culture

Three Steps To Succeed With Digital Transformation In Pharma?

Three Steps To Succeed With Digital...

Partnering With A Cdmo For Successful Late Phase Biologic Drug Product Development And Launch

Partnering With A Cdmo For Successful...

Data analysis for next-generation sequencing worth USD1.2 billion by 2026 - Cloud-based platforms emerging as preferred solutions

Life Sciences Review | Tuesday, March 29, 2022
Tweet

Global Next Generation Sequencing (NGS) Data Analysis Market to Reach US$1.2 Billion by the Year 2026


FREMONT, CA: The widespread adoption of the technology for analyzing RNA and DNA sequences is expected to fuel growth in the global market. Cloud-based  platforms are quickly becoming popular for executing computationally intensive operations during NGS data analysis because they make it quick and easy for researchers to obtain computational resources for large-scale NGS data analysis. Recent advances in cloud computing and bioinformatics have resulted in the creation of a diverse set of cloud-based bioinformatics platforms and services for large-scale NGS data processing, which is expected to drive significant market growth in the coming years.


NGS approaches are widely used in genomic research, clinical diagnostics, and precision medicine in oncology, particularly for the diagnosis of breast and lung tumors. Soon, the worldwide NGS data analysis market is predicted to develop due to the rising prevalence of cancer cases around the world. Furthermore, as significant progress is made toward individualized illness therapy, there is a greater demand for fast and precise sequencing interpretation algorithms and tools that can aid in data analysis.


Despite the COVID-19 dilemma, the global market for Next Generation Sequencing (NGS) Data Analysis, which was anticipated to be worth USD 549.2 million in 2020, is expected to expand to USD 1.2 billion by 2026, at a CAGR of 14.1 percent. Services- one of the report's segments, is expected to increase at a 14.9 percent compound annual growth rate to reach USD 814.1 million by the conclusion of the analysis period.


After a careful examination of the pandemic's commercial effects and the resulting economic crisis, the NGS Commercial Software segment's growth is revised to 13 percent CAGR for the next seven years. This sector now controls  44 percent of the global market for Next Generation Sequencing (NGS) Data Analysis.


The increased awareness and expanding demand for sequencing technologies are projected to propel the expansion of analytical software over the next few years. The massive amounts of data created by NGS necessitate management systems and solutions, increasing the demand for algorithms and tools. Companies that lack the infrastructure for data analysis, interpretation, and management are increasingly turning to NGS data analysis services.


 


Weekly Brief

loading
Top 10 Emerging Next Generation Sequencing Companies In Europe- 2022
Top 10 Next-Generation Sequencing Solutions Companies in Europe – 2022
Top 10 Emerging Next Generation Sequencing Companies In Europe- 2022
Top 10 Next-Generation Sequencing Solutions Companies in Europe – 2022
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Everything You Need to Know About Medical Lab Equipment and their Applications

Everything You Need to Know About Medical Lab Equipment and their Applications

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

The several benefits Of Agricultural Genome Editing

The several benefits Of Agricultural Genome Editing
Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks To Buy In 2022

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/data-analysis-for-nextgeneration-sequencing-worth-usd12-billion-by-2026-cloudbased-platforms-emerging-as-preferred-solutions-nwid-739.html